CYP 3.85% 25.0¢ cynata therapeutics limited

The Science Will Do The Talking, page-159

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    https://www.mesoblast.com/images/pdf/MSB_2019_Annual_Report_AR_ASX.pdf

    again....ITS ALL ABOUT MANUFACTURING.

    page 20.
    "Before we can begin commercial manufacture of our products for sale in the United States, we must obtain FDA regulatory approval for the product, in addition to the approval of the processes and quality systems associated with the manufacturing of such product, which requires a successful FDA inspection of the facility handling the manufacturing of our product, including Lonza’s manufacturing facilities. The novel nature of our product candidates creates significant challenges in regards to manufacturing. For example, the U.S. federal and state governments and other jurisdictions impose restrictions on the acquisition and use of tissue, including those incorporated in federal Good Tissue Practice regulations. We may not be able to identify or develop sources for the cells necessary for our product candidates that comply with these laws and regulations. Further, we may be required to conduct additional clinical trials using 3D manufacturing processes before we receive regulatory approval."
    The mythical "ready to go" 3D dream machine Barman claims is all ready to go.....LOL
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.010(3.85%)
Mkt cap ! $44.90M
Open High Low Value Volume
26.0¢ 26.5¢ 25.0¢ $5.869K 22.42K

Buyers (Bids)

No. Vol. Price($)
1 29342 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 30000 1
View Market Depth
Last trade - 15.47pm 11/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.